- Abstract:
-
Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy and in those with a kidney transplant. Since the publication of the original Kidney Disease: Improving Global Outcomes (KDIGO) HCV Guideline in 2008, major advances in HCV management, particularly with the advent of direct-acting antiviral therapies, have now made the cure of HCV possible in CKD patients. In ad...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's Version
- Publisher:
- Elsevier Publisher's website
- Journal:
- Kidney International Journal website
- Volume:
- 94
- Issue:
- 4
- Pages:
- 663-673
- Publication date:
- 2019-02-26
- Acceptance date:
- 2019-02-26
- DOI:
- EISSN:
-
1523-1755
- ISSN:
-
0085-2538
- Pubs id:
-
pubs:921082
- URN:
-
uri:b371769e-8d62-4e8c-8915-95388342e67a
- UUID:
-
uuid:b371769e-8d62-4e8c-8915-95388342e67a
- Local pid:
- pubs:921082
- Copyright holder:
- KDIGO
- Copyright date:
- 2019
- Notes:
- © 2018, KDIGO. Published by Elsevier on behalf of the International Society of Nephrology. This is an open access article under the CC BY-NC-ND license.
Journal article
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record